@article {SOBCZY{\'N}SKA-RAK1175, author = {ALEKSANDRA SOBCZY{\'N}SKA-RAK and BEATA {\.Z}YLI{\'N}SKA and {\L}UKASZ JAROSZ and ADAM BRODZKI and MARCIN TATARA}, title = {EGF Level in Hepatoid Gland Adenomas and Hepatoid Gland Epitheliomas in Dogs After Administering Tamoxifen}, volume = {32}, number = {5}, pages = {1175--1181}, year = {2018}, doi = {10.21873/invivo.11361}, publisher = {International Institute of Anticancer Research}, abstract = {Background/Aim: Neoplastic lesions of perianal glands account for approximately 10\% of all skin cancer cases in dogs. They occur in many dog breeds, usually in male animals aged over 6 years. Due to their hormone-dependency, tamoxifen can be used in antineoplastic treatment. The aim of the study was to measure epidermal growth factor (EGF) levels in the serum of dogs with perianal tumours after tamoxifen treatment and to use it as a prognostic factor for further treatment. Materials and Methods: The study was performed on 19 male dogs aged between 6 and 14 years, diagnosed with neoplastic hyperplasia in the perianal region. The control group comprised 10 healthy dogs brought in for routine castration. The research material comprised blood drawn from the animals and tumour specimens for histopathology. The study group received 1-month treatment with tamoxifen. Blood serum was then tested for 17-β oestradiol level, and for EGF level on the first day of the therapy and 6 months after treatment completion. Results: Hepatoid gland adenomas were diagnosed in 10 cases, and hepatoid gland epitheliomas in nine cases. Elevated 17-β oestradiol levels were observed in all dogs. On the first day of treatment with tamoxifen, the serum EGF levels in all study groups were higher than in the control group. At the 6-month follow-up, the EGF levels were significantly reduced in hepatoid gland adenoma cases compared to those taken on the first day of treatment of tamoxifen, while in animals with hepatoid gland epithelioma, it was greatly increased and was correlated with relapse. Conclusion: Perianal gland tumours are characterised by EGF overexpression, which can be helpful in early-stage prognosis and treatment. An increase in EGF levels 6 months after tamoxifen therapy correlates with disease progression and may be a useful prognostic factor.}, issn = {0258-851X}, URL = {https://iv.iiarjournals.org/content/32/5/1175}, eprint = {https://iv.iiarjournals.org/content/32/5/1175.full.pdf}, journal = {In Vivo} }